AzTrials
AzTrials

Prosthesis DurabilityNCT06031506

Management of Severely Atrophied Maxillary Ridge Using Quad Zygomatic Implants

A study testing Implant supported hybrid maxillary prosthesis in people with Prosthesis Durability, run by Mansoura University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This clinical study will aim to compare and evaluate zygomatic implant stability, occlusal contact, and bone level changes around dental implants Read more about this study

Who is it for?
Ages 45 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Prosthesis Durability
What is being tested?
Implant supported hybrid maxillary prosthesis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteEgypt
Study dates
15 Dec 2022to 16 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All patients will have healthy healed residual alveolar ridges, Angle's class I maxillomandibular relations, available maxillary restorative space. This will be verified by tentative jaw relation records.

Who cannot join

  • All detrimental bad habits like smoking, TMJ clicking or TMJ dysfunction will be excluded.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Mansoura University ,Faculty of dentistry

    Al Mansurah, P.O.Box:35516

Other trials in Egypt

About this study

Official title: Management of Severely Atrophied Maxillary Ridge Using Quad Zygomatic Implants to Support Immediately Loaded Hybrid Prosthesis.One Year Evaluation of Occlusal Contact and Ridge Resorption

This clinical study will aim to compare and evaluate zygomatic implant stability, occlusal contact, and bone level changes around dental implants

Read the detailed description

The aim of this study will be to compare and evaluate zygomatic implant stability, occlusal contact, and bone level changes around dental implants and that of the atrophied maxilla rehabilitated with immediate loaded hyprid prosthesis supported by 4 zygomatic implants.

Being tested
Implant supported hybrid maxillary prosthesis
Medical subject headings
Prosthesis Failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Implant supported hybrid maxillary prosthesisDevice

    All patients will receive immediately loaded hybrid prosthesis supported by 4 zygomatic implants.

Study groups in NCT06031506
Study groupRoleWhat they receive
quad zygomatic hybrid maxillary prosthesisExperimentalAll patients will be rehabilitated with immediate loaded hybrid prosthesis supported by 4 zygomatic implants.
Receives: Device: Implant supported hybrid maxillary prosthesis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. patient satisfaction

    The patient satisfaction will be evaluated using the visual analog scale (VAS) questionnaire at base line, 6, and 12 months later

    Measured: one year

  2. marginal implant bone loss

    The implant marginal bone height changes will be measured radiographically at base line, 6, and 12 months later

    Measured: one year

Secondary outcomes (1)
  1. posterior area index

    the area index of the anterior and posterior maxillary ridge will be measured radiographically at base line, 6, and 12 months later

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2023
  2. Study start15 Dec 2022
  3. Primary completion7 Mar 2023
  4. Study completion16 Jun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
All patients will receive conventional maxillary and mandibular complete dentures The implant size will be selected for each area according to the available bone length and width as measured by CBCT radiograph. All implants will be surgically installed guided by steriolethognathic stents \- Multi-unit abutments will be connected to implants and will be immedietly loaded by fixed full arch screw retained provisional acrylic restoration. Final prosthesis will be delivered 6-8 months later
Masking
None (open label)
Enrolment
15 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06031506
Sponsor's protocol ID
M03071221
Status last verified
Sep 2023
First submitted
4 Sep 2023
Last updated
11 Sep 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Implant supported hybrid maxillary prosthesis in people with Prosthesis Durability, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

patient satisfaction (time frame: one year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in